Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.
NCI Provides $40 Million To Four Centers For Cancer Communications Research.
Talpin To Join NCI
Pat Barr, Early NBCC Activist, Dead.
Cancer Groups Criticize Prescription Drug Bills.
AstraZeneca To Pay $335M In Illegal Pricing Penalties.
GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.
Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - Ian Krop named section chief of Medical Oncology and Hematology and deputy director for Clinical Affairs at Yale









